Graham Corporation GHM
70.19 USD -3.73 (-5.05%)
Nov 4, 2026, 2:50 PM EST
68.13 Day range 75.81
52.57 52-week range 125.82
- YTD
- +9.28%
- 1 year
- +13.26%
Analyst view
Consensus: buy
Buy
Price target (mean) 128.60 +83.2% upside
Now 70.19
- Target (low)
- 120.00
- Target (mean)
- 128.60
- Target (high)
- 135.00
Ratings (0m) 6 5 buy · 1 hold · 0 sell
- Strong buy2
- Buy3
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 6
- 1 month ago 5
- 2 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.42872 | 0.41 – 0.45 | 0.31 | +38.3% | 71.07M | +7.6% | 4 |
| Next quarter | 0.37186 | 0.23 – 0.43 | 0.31 | +20.0% | 69.37M | +22.3% | 5 |
| Current year | 1.81 | 1.56 – 1.95 | 1.40 | +29.0% | 290.98M | +18.6% | 5 |
| Next year | 2.28 | 2.11 – 2.37 | 1.81 | +26.0% | 323.23M | +11.1% | 5 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 2, 2026 | JP Morgan | Initiated | — | Overweight |
| Jun 25, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Jun 23, 2026 | Northland Capital Markets | Maintained | Outperform | Outperform |
| Jun 9, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Mar 18, 2026 | Oppenheimer | Initiated | — | Outperform |
| Jun 23, 2025 | Northland Capital Markets | Initiated | — | Outperform |
| Jun 24, 2024 | Noble Capital Markets | Initiated | — | Outperform |
| Feb 8, 2022 | Maxim Group | Maintained | — | Buy |
| Feb 8, 2022 | Colliers Securities | Downgrade | Buy | Neutral |
| Apr 18, 2019 | Maxim Group | Initiated | — | Buy |
| Feb 4, 2013 | Roth Capital | Downgrade | Buy | Neutral |
| Sep 24, 2012 | CJS Securities | Initiated | — | Market Perform |